UBC is a leader in safety and risk management strategies and systems
to guide the use of biopharmaceuticals, medical devices, and other
health care products. Our experts in product safety, risk
management, epidemiology, and health policy collaborate with an
array of health system stakeholders, including providers,
regulators, payers, and manufacturers to identify, assess, and
address issues that may impact patient safety.
We help protect patients and address regulatory requirements by
designing and implementing Risk Evaluation and Mitigation Strategies
and Risk Management Plans. UBC has unsurpassed experience
developing and executing product safety and risk management
programs, such as observational risk assessment studies – or
registries – and comprehensive pharmacovigilance and safety
UBC safety and risk management programs are designed by recognized
experts, executed by industry-leading research operations
professionals, and supported by reliable, customized technologies
including our state-of-the-art Risk Management Coordinating Center.
Our systems and technologies are tailored to address individual
project needs and are designed to comply with key industry
guidelines and regulations, including 21 CFR Part 11 and HIPAA.